Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypotonia as a Clinical Predictor of Optic Pathway Glioma in Children With Neurofibromatosis Type 1

NCT02584413 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02584413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02584413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypotonia as a Clinical Predictor of Optic Pathway Glioma in Children With Neurofibromatosis Type 1
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Terminated
Start date
April 16, 2013
Completion date
February 7, 2019
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1